Ginoring, (0,120 mg +0,015 mg)/24 h, system terapeutyczny dopochwowy, 1 szt.
Liczba opakowań:
Ginoring - Etonogestrelum, Ethinylestradiolum
- use and effects

Active ingredient:

Etonogestrelum, Ethinylestradiolum
Ginoring-Download the patient information leaflet

Before use, read the patient information leaflet which contains instructions, contraindications, information on adverse drug reactions and dosage as well as directions for use of the medicinal product, or consult a doctor or a pharmacist, as every drug may be hazardous to your health and life if used improperly.